Details for New Drug Application (NDA): 207985
✉ Email this page to a colleague
The generic ingredient in FINGOLIMOD HYDROCHLORIDE is fingolimod hydrochloride. There are twenty-one drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the fingolimod hydrochloride profile page.
Summary for 207985
| Tradename: | FINGOLIMOD HYDROCHLORIDE |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | fingolimod hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 207985
| Mechanism of Action | Sphingosine 1-Phosphate Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 207985
Suppliers and Packaging for NDA: 207985
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FINGOLIMOD HYDROCHLORIDE | fingolimod hydrochloride | CAPSULE;ORAL | 207985 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-166 | 68462-166-07 | 7 BLISTER PACK in 1 CARTON (68462-166-07) / 7 CAPSULE in 1 BLISTER PACK |
| FINGOLIMOD HYDROCHLORIDE | fingolimod hydrochloride | CAPSULE;ORAL | 207985 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-166 | 68462-166-15 | 28 CARTON in 1 CARTON (68462-166-15) / 14 BLISTER PACK in 1 CARTON (68462-166-41) / 14 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 0.5MG BASE | ||||
| Approval Date: | Jun 18, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
